1.17

1.69% -0.02

Lineage Cell Therapeutics Inc (LCTX)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.19

Offen:

$1.18

24-Stunden-Volumen:

439.78K

Relative Volume:

0.18

Marktkapitalisierung:

$266.04M

Einnahmen:

$8.95M

Nettoeinkommen (Verlust:

$-21.49M

KGV:

-9.75

EPS:

-0.12

Netto-Cashflow:

$-29.24M

1W Leistung:

+14.70%

1M Leistung:

+23.89%

6M Leistung:

+73.06%

1J Leistung:

+28.80%

1-Tages-Spanne:

$1.15

$1.185

1-Wochen-Bereich:

$1.0294

$1.31

52-Wochen-Spanne:

$0.3651

$1.31

Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile

Firmenname

Lineage Cell Therapeutics Inc

Sektor

Healthcare (1159)

Branche

Biotechnology (645)

Telefon

510-871-4188

Adresse

2173 Salk Avenue, Suite 200, Carlsbad, CA

Mitarbeiter

Twitter

@LineageCell

Nächster Verdiensttermin

2025-03-10

Neueste SEC-Einreichungen

LCTX's Discussions on Twitter

Vergleichen Sie LCTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LCTX Lineage Cell Therapeutics Inc	1.165	292.30M	8.95M	-21.49M	-29.24M	-0.12
VRTX Vertex Pharmaceuticals Inc	397.27	99.96B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	604.87	60.83B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	465.72	59.89B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	667.34	40.47B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	310.73	37.96B	3.81B	-644.79M	-669.77M	-6.24

Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-20	Eingeleitet	Craig Hallum	Buy
2022-11-02	Eingeleitet	Robert W. Baird	Outperform
2022-06-14	Eingeleitet	B. Riley Securities	Buy
2021-08-19	Eingeleitet	Noble Capital Markets	Outperform
2021-03-31	Eingeleitet	Cantor Fitzgerald	Overweight

Lineage Cell Therapeutics Inc Aktie (LCTX) Neueste Nachrichten

Aug 20, 2025

Published on: 2025-08-21 02:00:17 - kangso.co.kr

Aug 20, 2025

Aug 18, 2025

How to track smart money flows in Lineage Cell Therapeutics Inc.Weekly Earnings Recap & Community Verified Trade Signals - Newser

Aug 18, 2025

Trend Reversal Possible in Lineage Cell Therapeutics Inc. Charts IndicateAnalyst Upgrade & AI Enhanced Trade Execution Alerts - beatles.ru

Aug 18, 2025

Aug 17, 2025

Will breakout in Lineage Cell Therapeutics Inc. lead to full recoveryJuly 2025 Technicals & Accurate Intraday Trading Signals - Newser

Aug 17, 2025

Heatmap analysis for Lineage Cell Therapeutics Inc. and competitorsBear Alert & AI Powered Buy and Sell Recommendations - Newser

Aug 17, 2025

Aug 16, 2025

Is Lineage Cell Therapeutics Inc. stock a value trapWeekly Volume Report & Weekly Momentum Picks - thegnnews.com

Aug 16, 2025

Published on: 2025-08-17 09:06:42 - mustnews.co.kr

Aug 16, 2025

How to recover losses in Lineage Cell Therapeutics Inc. stockQuarterly Profit Summary & Safe Capital Growth Stock Tips - Newser

Aug 16, 2025

Combining price and volume data for Lineage Cell Therapeutics Inc.2025 Top Gainers & Technical Confirmation Trade Alerts - Newser

Aug 16, 2025

What does recent volatility data suggest for Lineage Cell Therapeutics Inc.2025 Market Trends & Risk Adjusted Swing Trade Ideas - Newser

Aug 16, 2025

Aug 15, 2025

Relative strength of Lineage Cell Therapeutics Inc. in sector analysisGDP Growth & Safe Entry Trade Reports - Newser

Aug 15, 2025

Applying Wyckoff theory to Lineage Cell Therapeutics Inc. stockWeekly Stock Recap & Reliable Intraday Trade Alerts - Newser

Aug 15, 2025

What data driven models say about Lineage Cell Therapeutics Inc.’s futureJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser

Aug 15, 2025

Lineage Cell (LCTX) Surges 25% Intraday: Algorithmic Frenzy or Retail Rally? - AInvest

Aug 15, 2025

Behind Lineage Cell Therapeutics Inc’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

Aug 15, 2025

Lineage Cell Surges 24.5% on Biotech Sector Rally: What's Fueling the Momentum? - AInvest

Aug 15, 2025

Lineage Cell (LCTX.A) Surges 14.7% — Was It Driven by Order Flow or Sector Momentum? - AInvest

Aug 15, 2025

Risk adjusted return profile for Lineage Cell Therapeutics Inc. analyzedTrade Exit Report & Community Consensus Picks - Newser

Aug 15, 2025

Exit strategy if you’re trapped in Lineage Cell Therapeutics Inc.Take Profit & Real-Time Chart Breakout Alerts - Newser

Aug 15, 2025

Aug 14, 2025

Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics - TipRanks

Aug 14, 2025

Craig-Hallum Keeps Their Buy Rating on Lineage Therap (LCTX) - The Globe and Mail

Aug 14, 2025

Will Lineage Cell Therapeutics Inc. Benefit From Broader Market BounceNew Guidance & Weekly High Return Opportunities - sundaytimes.kr

Aug 14, 2025

Detecting support and resistance levels for Lineage Cell Therapeutics Inc.July 2025 Volume & Free Community Supported Trade Ideas - Newser

Aug 14, 2025

Aug 13, 2025

How to build a dashboard for Lineage Cell Therapeutics Inc. stock2025 Price Momentum & Low Risk Entry Point Guides - Newser

Aug 13, 2025

Is Lineage Cell Therapeutics Inc. stock ready for a breakout2025 Top Decliners & Weekly High Potential Stock Alerts - Newser

Aug 13, 2025

Analyzing recovery setups for Lineage Cell Therapeutics Inc. investors2025 Market Overview & Precise Buy Zone Tips - Newser

Aug 13, 2025

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q2 2025 Earnings Call Transcript - MSN

Aug 13, 2025

Lineage Cell Therapeutics: Strong Financials and Promising Clinical Data Drive Buy Rating - TipRanks

Aug 13, 2025

Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges - MSN

Aug 13, 2025

Lineage Cell: Q2 Earnings Snapshot - Stamford Advocate

Aug 13, 2025

Can a trend reversal in Lineage Cell Therapeutics Inc. lead to recoveryPortfolio Risk Report & Fast Exit Strategy with Risk Control - Newser

Aug 13, 2025

Lineage Cell Therapeutics (LCTX): Strategic Partnerships and Platform Expansion as Catalysts for Value Creation - AInvest

Aug 13, 2025